2025-05-16 - Analysis Report
Okay, here's a report analyzing Microstrategy (MSTR) based on the provided data.

## Microstrategy (MSTR) Analysis Report

**Ticker:** MSTR
**Company Name:** Microstrategy Inc.
**Description:** Microstrategy Inc. is a company that provides enterprise analytics software and services.

### 1. Performance vs. S&P 500 (VOO)

*   **MSTR Cumulative Return:** 1358.08%
*   **VOO Cumulative Return:** 81.82%
*   **Absolute Deviation:** 1276.3
*   **Deviation Range:** Min: -72.8, Max: 1990.6
*   **Relative Deviation:** 65.4

**Analysis:** MSTR has significantly outperformed the S&P 500 (VOO) over the analyzed period. The relative deviation of 65.4 indicates that MSTR's outperformance is positioned above the midpoint of its historical deviation range. This suggests that while the outperformance is substantial, there's still room for further gains based on historical trends.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD  | Alpha    | Beta    | Cap(B) |
|------------|---------|------|----------|---------|--------|
| 2015-2017  | -25.0%  | 56.6%| -54.0%   | -0.1    | 3.6    |
| 2016-2018  | -21.0%  | 62.6%| -39.0%   | -0.1    | 3.5    |
| 2017-2019  | -23.0%  | 62.6%| -52.0%   | -0.3    | 3.9    |
| 2018-2020  | 135.0%  | 62.6%| 110.0%   | -0.4    | 10.7   |
| 2019-2021  | 170.0%  | 71.0%| 116.0%   | -0.4    | 15.0   |
| 2020-2022  | 16.0%   | 72.7%| 9.0%     | -0.1    | 3.9    |
| 2021-2023  | 9.0%    | 72.7%| -8.0%    | 3.0     | 17.4   |
| 2022-2024  | 1384.0% | 72.7%| 1367.0%  | 3.1     | 80.0   |
| 2023-2025  | 1287.0% | 66.5%| 1257.0%  | 0.9     | 110.5  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate shows volatile performance.  The recent periods (2022-2025) show exceptional growth.
*   **MDD:** Maximum Drawdown is consistently high, indicating significant risk/volatility.
*   **Alpha:** Alpha is generally very high in the recent years, indicating significant outperformance relative to the market, adjusted for risk.
*   **Beta:** Beta values fluctuate, with some periods showing negative correlations with the market and recent ones a positive correlation.
*   **Cap(B):** Shows increase in market capitalization

### 2. Recent Price Action

*   **Current Price:** 399.94
*   **Last Market Data:** Price: 400.13, Previous Close: 416.75, Change: -3.99
*   **5-Day Moving Average:** 405.546
*   **20-Day Moving Average:** 368.5895
*   **60-Day Moving Average:** 316.1195

**Analysis:** The price has recently dipped below the 5-day moving average but remains above the 20 and 60-day moving averages. The recent price change of -3.99 indicates a short-term pullback.

### 3. Market Risk Indicators

*   **MRI:** 0.350 (Low Risk)
*   **RSI:** 75.42 (Overbought)
*   **PPO:** 0.3531
*   **Recent (20-day) Relative Deviation Change:** 2.1 (Short-term Increase)
*   **Expected Return:** 114.5% (Long-term, vs. S&P 500)

**Analysis:**

*   The MRI suggests a relatively low-risk environment, which could be misleading given MSTR's volatile history.
*   The RSI indicates that the stock is currently overbought, potentially signaling a near-term correction.
*   The PPO indicates that prices are high relative to past price.
*   The recent increase in relative deviation suggests continued short-term upward momentum.
*   The significant negative change in the last market data may indicate a short-term downward trend
*   The expected return suggests a potentially large outperformance vs the S&P 500 over the long term, but this should be considered alongside the high risk and volatility associated with MSTR.

### 4. Recent News & Significant Events

*   **2025-05-15:**  Major business developments, regulatory changes, or market events.
*   **2025-05-14:** Analyst discussions of recent performance and outlook.
*   **2025-05-16:**  Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-05-13:** Market experts highlight both risks and opportunities.

**Analysis:** Recent news highlights ongoing volatility and scrutiny surrounding MSTR, potentially driven by company-specific events, earnings, or executive decisions. Investors should closely monitor these developments.

### 5. Recent Earnings Analysis

| 날짜       | EPS    | 매출        |
|------------|--------|-------------|
| 2025-05-05 | -16.49 | 0.11 B$     |
| 2024-10-31 | -1.72  | 0.12 B$     |
| 2024-08-06 | -5.74  | 0.11 B$     |
| 2024-05-01 | -3.09  | 0.12 B$     |
| 2025-05-05 | -0.31  | 0.12 B$     |

**Analysis:** Microstrategy has consistently reported negative EPS figures over the recent quarters despite relatively stable revenue. This suggests potential issues with profitability. Investors should investigate the reasons for these losses.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-03-31   | $0.11B  | 69.41%        |
| 2024-12-31   | $0.12B  | 71.69%        |
| 2024-09-30   | $0.12B  | 70.41%        |
| 2024-06-30   | $0.11B  | 72.24%        |
| 2024-03-31   | $0.12B  | 73.96%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE      |
|--------------|------------|----------|
| 2025-03-31   | $33.53B    | -12.58%  |
| 2024-12-31   | $18.23B    | -3.68%   |
| 2024-09-30   | $3.77B     | -9.01%   |
| 2024-06-30   | $2.83B     | -3.62%   |
| 2024-03-31   | $2.40B     | -2.21%   |

**Analysis:**

*   **Revenue:**  Revenue is relatively consistent across the quarters.
*   **Profit Margin:** Profit margins are strong and relatively stable.
*   **Equity:** Equity has significantly increased, particularly in the most recent quarters.
*   **ROE:** Return on Equity is negative, which aligns with the negative EPS.

### 7. Overall Summary

Microstrategy (MSTR) has exhibited significant outperformance compared to the S&P 500, with recent years showing exponential growth, as reflected in high CAGR and Alpha values. The company's stock has notable volatility and is currently showing an overbought RSI, suggesting a potential near-term correction. While revenue and profit margins are strong, the company's negative EPS and ROE raise concerns about overall profitability. Recent news and events suggest a period of heightened attention and potential market influence. Investors should carefully weigh the risks and opportunities before considering an investment in MSTR, paying close attention to company announcements and market developments.
